Pura Vida Investments LLC

Search
⚲

Total AUM ($M) Copy

Sector	Form 13F Holdings	Value ($B)
	Oncocyte Corp	0.0
	Beta Bionics Inc	0.0
	Establishment Labs Holdings Inc	0.0
	Caris Life Sciences Inc	0.0
	InspireMD Inc	0.0
	Natera Inc	0.0
	Nvidia Corp	0.0
	J P Morgan Chase & Co	0.0
	Microsoft Corp	0.0
	Metagenomi Inc	0.0
View All

Holdings by Sector ($B)

Type	Form D Funds	Date	Sold	AUM
PE	Pura Vida X Fund LP	[2022-03-30]	17.5 M	30.2 M
	Filed 2021-07-02 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
HF	Pura Vida Pro Special Opportunity Master Fund Ltd	[2020-03-25]	55.9 M	1.9 M
	Filed 2024-11-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
PE	Pura Vida Private Equity Fund LP	[2016-03-14]	1.6 M	18.9 M
	Offered $1,610,000 · Filed 2016-01-05 (D) · Exemption 506(b) · Duration One year or less · Revenue Decline to Disclose
PE	Pura Vida SPV I LLC	[2014-10-28]	5.8 M	14.1 M
	Filed 2020-06-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Pura Vida Master Fund Ltd	[2013-01-24]	257.6 M	20.4 M
	Filed 2024-11-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose

AUM Breakdown	Accounts	AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	10	52.5
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	2	39.0
Total	12	91.5
By Discretionary
Discretionary	12	91.5
Non-Discretionary	0	0.0
Total	12	91.5
By Non-United States Persons
Non-United States Persons		20.4
United States Persons		71.1
Total	12	91.5

Form D Directors	Role	# Filings	# Firms
Pura Vida Investments LLC	Executive Officer	6	2
Pura Vida Funds Group GP LLC	Executive Officer	5	2
Efrem Kamen	Executive Officer	3	2
Pura Vida Pro LLC	Executive Officer	1	1
Shayne Sowers	Executive Officer	1	1
Narayan Krishnan	Executive Officer	1	1
Pura Vida Pro GP LLC	Executive Officer	1	1
Thomas Sowers	Executive Officer	1	1

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Pura Vida Investments LLC	Sonendo Inc	[2024-11-14]
Pura Vida Investments LLC	Oncocyte Corp	[2024-11-14]
Pura Vida Investments LLC	Cutera Inc	[2023-04-13]
Pura Vida Investments LLC	ICAD Inc	[2023-03-15]
Pura Vida Investments LLC	Oncocyte Corp	[2023-02-14]
Pura Vida Investments LLC	Quotient Ltd	[2023-02-14]
Pura Vida Investments LLC	APYX Medical Corp	[2022-11-23]
Pura Vida Investments LLC	Sonendo Inc	[2022-11-22]
Pura Vida Investments LLC	NanoString Technologies Inc	[2022-11-09]
Pura Vida Investments LLC	LYRA Therapeutics Inc	[2022-11-08]
View All

Insider Transaction (Form 3/4/5)	Date	Action	Shares	Price	Value ($)
Oncocyte Corp OCX Common Stock	2023-04-05	Buy	663,000	$0.30	198,900
Oncocyte Corp OCX Common Stock	2023-03-06	Other	3,890,111
Oncocyte Corp OCX Common Stock	2022-06-24	Sell	10,964	$1.05	11,512
Oncocyte Corp OCX Common Stock	2022-06-24	Sell	12,517	$1.05	13,143
Oncocyte Corp OCX Common Stock	2022-06-24	Sell	40,464	$1.03	41,678
Oncocyte Corp OCX Common Stock	2022-06-24	Sell	35,441	$1.03	36,504
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	767,952	$1.33	1,021,376
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	1,665,898	$1.33	2,215,644
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	30,790	$1.23	37,872
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	1,916,419	$1.33	2,548,837
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	57,630	$1.26	72,614
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	19,210	$1.23	23,628
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	92,370	$1.26	116,386
Oncocyte Corp OCX Warrant to purchase common stock · derivative	2022-04-14	Buy	690,719
Oncocyte Corp OCX Warrant to purchase common stock · derivative	2022-04-14	Buy	383,976
Oncocyte Corp OCX Warrant to purchase common stock · derivative	2022-04-14	Buy	832,949
Oncocyte Corp OCX Warrant to purchase common stock · derivative	2022-04-14	Buy	958,209
Oncocyte Corp OCX Common Stock	2022-04-14	Buy	1,381,438	$1.33	1,837,313
Stryve Foods Inc SNAX Class A Common Stock	2021-09-15	Sell	800,000
Stryve Foods Inc SNAX Prepaid Common Stock Purchase Warrant (right to buy) · derivative	2021-09-15	Buy	800,000
showing 20 of 92 most recent transactions

Comparable Firms	State	AUM
Ridgeline Productions LLC ✚	NY	115.4 M
Islet Management LP ✚	NY	108.8 M
Kalamata Asset Management LLC ✚	MD	106.8 M
Stonebridge Partners LLC ✚	NY	99.4 M
Arex Capital Management LP ✚	NY	99.4 M
S Muoio & Co LLC ✚	NY	95.1 M
Oxford Gate Management LLC ✚	CT	90.9 M
Seaport Global Asset Management LLC ✚	NY	80.0 M
Shoreline Capital Management Ltd ✚		75.9 M
Abry Partners LLC ✚	MA	69.3 M

Assets, Funds, Holdings